Nanotheranostics 2023; 7(4):368-379. doi:10.7150/ntno.82263 This issue Cite
Review
1. Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Ahmedabad, Gujarat 380009, India.
2. Department of Pharmacology, L. M. College of Pharmacy, Niangua, Ahmedabad, Gujarat 380009, India.
3. PharmD Section, L.M. College of Pharmacy, Ahmedabad, Gujarat 380009, India.
4. Pharmacy Section, L.M. College of Pharmacy, Ahmedabad, Gujarat 380009, India.
5. School of Pharmacy, Queen's University Belfast, 97 Lilburn Road, BT9 7BL, U.K
Cancer diagnosis and management have been a slow-evolving area in medical science. Conventional therapies have by far proved to have various limitations. Also, the concept of immunotherapy which was thought to revolutionize the management of cancer has presented its range of drawbacks. To overcome these limitations nanoparticulate-derived diagnostic and therapeutic strategies are emerging. These nanomaterials are to be explored as they serve as a prospect for cancer theranostics. Nanoparticles have a significant yet unclear role in screening as well as therapy of cancer. However, nanogels and Photodynamic therapy is one such approach to be developed in cancer theranostics. Photoactive cancer theranostics is a vivid area that might prove to help manage cancer. Also, the utilization of the quantum dots as a diagnostic tool and to selectively kill cancer cells, especially in CNS tumors. Additionally, the redox-sensitive micelles targeting the tumor microenvironment of the cancer are also an important theranostic tool. This review focuses on exploring various agents that are currently being studied or can further be studied as cancer theranostics.
Keywords: nanoparticles, cancer, theranostics, photosensitive agents, photodynamic therapy, photothermal therapy